Pharmacology I: Lecture 6 - Opioids/NSAIDs Flashcards

(113 cards)

1
Q

What is the origin of opioids?

A

Derived from unripe seed pods of the opium poppy containing opium alkaloids

Opium is harvested and processed into heroin as well as pharmaceutical drugs

The word opium itself is derived from the Greek name for juice – opium alkaloids are isolated from the dried milky juice of the opium poppy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name the four families of alkaloids.

A
  • Opiates
  • Caffeine
  • Cocaine
  • Nicotine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What historical event involved the opium trade in the 1800s?

A

The Opium Wars between China and Western powers

The first historical reference to poppy was around 4000 BC

Was touted as a cure for alcoholism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When was Morphine first isolated?

A

1st isolated in 1806 and named morphine after Morpheus the Greek god of dreams

There use led to the Harrison Narcotics Act of 1914 which criminalized narcotic possession

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What does the term ‘opiate’ refer to?

A

Drugs derived from opium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define ‘opioids’.

A

All substances, both natural and synthetic, that bind to opioid receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does ‘narcotic’ refer to?

A

Any substance with addictive potential that alters mood and behavior, inducing sleep and euphoria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the structure of morphine?

A

Naturally-occurring
Morphine Benzylisoquinolines

The classical opiate alkaloid morphine consists of a pentacyclic ring

Substitutions to this ring are how other opioids are made

Semi-synthetic
Hydromorphone
Oxycodone
Heroin

Synthetic
Fentanyl (and derivatives)
Meperidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Name three endogenous opioids produced by the body.

A
  • Endorphin
  • Enkephalin
  • Dynorphin

An opiate-like substance produced by the body – natural opioids

They are detectable as opioid peptides and are involved in the stress response
Role in pain, stress, tissue injury, and inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the mechanism of action of opioids?

A

Agonist with activation of opioid receptors, primarily in the brain and spinal cord

Affinity for opioid receptors correlates well with their analgesic potency
Full agonist are highly potent and only require a little receptor occupancy for maximal response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Mechanims of Action Process

A

Opioid receptors: G protein coupled receptors
seven transmembrane portions, intracellular and extracellular loops, an extracellular N-terminus, and an intracellular C-terminus

Once bound the receptor undergoes a conformational change and reaches a state of high affinity for G proteins
Affinity: Full, Partial, Antag, or Agon-Antag

This results in reduced cAMP levels, inhibition of Ca2+ current, and increase of K+ current

Which ultimately culminate to hyperpolarize the cell and reduce neuronal excitation and inhibit neurotransmitter release

Activation causes increased K+ conductance and Ca++ channel inactivation leading to decreased neurotransmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the three distinct opioid receptors?

A

Subset of G (guanine) protein coupled receptors

  • Mu (μ 1 & 2)
  • Kappa (κ 1a, 1b, 2, & 3)
  • Delta (δ 1 & 2)

Further subdivided into subtypes based on diversity of binding and effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the primary role of the Mu (μ) receptor?

A

Responsible for analgesia

Universal site for endogenous ligands (RUNNERS HIGH???)

Mu-1: analgesia

Mu-2: hypoventilation, ↓HR, & dependence (this is where the drugs that try and get someone over addiction work)

Subset of G (guanine) protein coupled receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the primary role of the Kappa (k) receptor?

A

Endogenous ligands: dynorphins

Produces less respiratory depression than μ

Causes dysphoria and diuresis

Subset of G (guanine) protein coupled receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the primary role of the Delta (Δ)
receptor?

A

Endogenous ligand: enkephalins

Thought to modulate the activity of μ (if binds to Delta, it will enhance the substances binding to the Mu)

Subset of G (guanine) protein coupled receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

True or False: Kappa (κ) receptors produce more respiratory depression than Mu (μ) receptors.

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the pharmacodynamic effects of acute opioid exposure?

A
  • Antitussive
  • CV inhibition
  • Depress GI system
  • Nausea/Vomiting
  • Pruritus
  • Sedation
  • Miosis
  • Analgesic
  • Respiratory depression
  • Euphoria/CNS stimulation
  • Skeletal muscle rigidity
  • Smooth muscle spasm (biliary spasm, urinary retention, and constipation)
  • Histamine release

Depressed cellular immunity big one right now = opioids hurt killer t cells production, which for someone with cancer, this might not be good… trying to move towards opioid free anesthesia for them

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Miosis vs Mydriasis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the effect of chronic opioid exposure?

A
  • Desensitization
  • Tolerance
  • Dependence
  • Hyperalgesia (one that is commonly overlooked, reconfiguring the neurons that results in less of a stimulus to create an increased pain response)
  • Immunosuppression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

PK of Opiates and Opioids

A

Absorption/Distribution
Depends of the ROA

Metabolism
Most all via CYP 450 enzymes to inactive
A few are prodrugs or have active metabolites
Remifentanil is unique

Elimination
Metabolites are excreted in the urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the primary route of administration (ROA) for opioids?

A
  • IV
  • Oral
  • IM
  • Transdermal
  • Intrathecal
  • Epidural
  • Transmucosal, SQ, and Inhalational are available
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Bolus Front to Back End Kinetics

A

Remi and Alfen are the quickest onset, fastes offset - could use this for an induction dose when wanting to stay away from muscle relaxant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Not a formal question and answer slide…

Infusions Front-End Kinetcs

A

Infusions Back-End Kinetics

Fentanyl repeated boluses actually act like an infusion and are thus longer acting than hydromorphone or morphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Opioid Induced Ventilatory Depression

A

The depression of ventilation is studied by artificially increasing inspired carbon dioxide while maintaining normal oxygen tension.28As shown inFig. 17.9, an increase in arterial carbon dioxide partial pressure dramatically increases the minute ventilation. Under the influence of opioid analgesics, the curve is flattened and shifted to the right such that at a given carbon dioxide partial pressure the minute ventilation is lower.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Morphine Names and History
Duramorph MS Cotin DepoDur Astramorph First isolated in 1804 by a German pharmacist Named after Morpheus, the Greek god of dreams Cause of “Soldier’s Disease” during the American Civil War Heroin was derived from morphine in 1874
26
Structure of Morphine
Prototype opioid agonist Effects: Analgesia Euphoria **Sedation** Diminished ability to concentrate **Relieves continuous, dull pain more effectively than intense sharp pain (somatic)**
27
Distribution and Elimination of Morphine
Poor penetration of BBB increases effect site equilibration time because…. Relatively poor lipid solubility High degree of ionization Highly protein bound Hepatic conjugation with glucuronic acid Active metabolite: morphine-6-glucuronide (M6G) >>> M3G
28
What is the active metabolite of morphine?
Morphine-6-glucuronide (M6G)
29
Clinical Effects of Morphine
Cardio: ↓HR,↓BP, depression Resp: Ventilation depression -↓RR,↑TV (slow and deep) CNS: ↓CBF with ↓ICP... ...sedation conversely↑PaCO2 → ↑ ICP (this will ultimately overtake the decrease effects)
30
Clinical Considerations of Morphine
Slow onset (15 – 20 min) and offset IV DOA: 3 – 4 hrs Active metabolite – M6G Histamine release Cough suppression Skeletal muscle rigidity Biliary spasm Miosis Decreased gastric emptying Constipation Nausea and vomiting Free placental transfer
31
Packaging and Dosing of Morphine
Commercial preparation 0.1% morphine sulfate Duramorph®: PF Epidural: 1 mg/cc Spinal: 0.2 mg/cc Dosing IVP: 1 – 2 mg - Peds IVP 0.1 mg Intravenous: 0.05 – 0.2 mg/kg Epidural: 2 mg Spinal: 0.2 mg Used the most in C-Sections during neuroaxial anesthesia, because it doesnt pass easily through lipid barrier/BBB, won't diffuse out of the space as easy and wont pass to baby as easy
32
What is Meperidine commonly known as?
Demerol
33
Structure of Demerol
Synthetic Mu agonist derived from phenylepiperidine Prologue of many opioids Shares structural similarity: Local anesthetics Amine, ester, phenyl Atropine Weak antimuscarinic effect Antispasmodic effect
34
Distribution and Elimination of Demerol
Well absorbed from the GI tract Extensive hepatic metabolism Demethylation to normeperidine Ester Hydrolysis to meperidinic acid Renal excretion
35
Clinical Uses of Demerol
Analgesia Labor & delivery Post-surgery PCA Peds Post-operative shivering (decreases it)
36
Clinical Considerations of Demerol
Cardio: ↓BP,↑HR, myocardial depression Resp: ventilatory depression CNS: delirium, seizures Other: Free placental transfer Mydriasis Dry mouth **Toxic with MAOI – Serotonin Syndrome**
37
Packaging & Dosing of Demerol
Commercial preparation 50 mg/cc meperidine hydrochloride Dosing IVP 50 – 100 mg Peds IVP 10 mg 0.5 – 2 mg/kg
38
History of Fentanyl
Synthesized in 1960s in Belgium Recreational use at “China White” in 70s
39
Structure of Fentanyl
Phenylpiperidine-derivative 75-125x more potent than morphine Rapid onset and short duration of action due to extremely lipophilic
40
Distribution and Elmination of Fentanyl
Rapid onset and high potency reflect high lipid solubility Large tissue reservoir extend duration of action High first pass pulmonary uptake Hepatic P450 demethylation to norfentanil metabolites (inactive)
41
Clinical Uses of Fentanyl
Analgesia Operative IV SAB Epidural Intranasal Chronic pain Transmucosal Transdermal
42
Clinical Considerations of Fentanyl
Cardio: ↓HR, mild ↓CO Resp: depression CNS: mild ↑ICP Other: Profound synergism with benzodiazepines Reflex coughing Skeletal muscle rigidity
43
Packaging and Dosing of Fentanyl
Commercial preparation 50 mcg/cc fentanyl citrate Duragesic©: 12.5 – 100 mcg/hr Dosing IVP: 1 mcg/kg or 50 – 100 mcg Peds IVP: 5 mcg Intravenous: 0.5-2 mcg/kg Intrathecal: 5-25 mcg Sublingual: 5-20 mcg/kg Infusion: 1.5 – 3 mcg/kg/hr
44
What is the potency of Fentanyl (Sublimaze) compared to morphine?
75-125 times more potent than morphine
45
Structure of Sufenta (Sufentanil)?
Thienyl analogue of fentanyl 10x potency as fentanyl
46
Distribution and Elimination of Sufenta
Rapid onset and redistribution reflect the high degree of lipid solubility of sufentanil Significant first pass pulmonary effect (60%) Same Elimination 1/2 time Lipid solubility = rapid crossing of BBB & onset Less accumulation compaired to fentanyl (in adipose tissue) Hepatic dealkylation and demethylation to desmethyl sufentanil
47
Packaging and Dosing of Sufenta
Commercial preparation 50 mcg/cc sufentanil hydrochloride DOA: 10 – 20 min Dosing IVP: 5 – 10 mcg IV: 0.05 – 0.2 mcg/kg Infusion: 0.1 – 0.4 mcg/kg/hr
48
What is the clinical use of Sufentanil?
Analgesia with 10x potency compared to Fentanyl
49
Structure of Alfentanil (Alfenta)?
Analogue of fentanyl 20% potency of fentanyl 30% duration of fentanyl
50
Distribution and Elimination of Alfenta
Rapid effect-site equilibration due to↓pK **Vd = fentanyl > sufentanil > alfentanil > remifentanil** 90% of drug exists as non-ionized which can cross the BBB **Interaction with erythromycin will ↓ metabolism** Hepatic metabolism via dealkylation Piperidine to noralfentanil
51
Packaging and Dosing of Alfenta
Commercial preparation 500 mcg/cc alfentanil hydrochloride Dosing IV: 15 – 30 mcg/kg Infusion: 15 – 25 mcg/kg/hr
52
Structure of Remifentanil (Ultiva)
**Chemically related to fentanyl of phenylpiperidine, but with a unique ester linkage** Potency equal to fentanyl Duration equal to alfentanil Selective Mu opioid agonist
53
Characteristics of Ultiva
Brevity of action Precise Rapidly titratable Non-cumulative effect **Rapid recovery** **Great of infusions or short stimulations** **Continued infusion causes hyperalgesia** (great for procedures that are 40-60 minutes to avoid this, but then flip side for long surgeries you know they will wake up) ## Footnote Used at every teaching facility across the US, because very forgiving if the students mess up
53
Distribution and Elimination of Ultiva
Small Vd and extremely rapid clearance Dealkylation metabolism by non-specific plasma and tissue esterases (when metbolized by esterases, off set is quick) 99.8% of remifentanil is eliminated in less then six minutes Minimum accumulation seen no matter how long infusion is running Prolonged infusion results in hyperalgesia
54
Dosing and Clinical Effects of Ultiva
Commercial preparation 2 mg/cc remifentanil hydrochloride Dosing IV: 0.25 mcg/kg Infusion: 0.1 – 0.5 mcg/kg/min
55
Hydromorphone (Dilaudid) Basics
Is a derivative of morphine A semi-synthetic Mu agonist Structure change increases its lipid solubility and ability to cross the BBB 3 – 4x as potent but shorter DOA Hepatic metabolism by CYP 450 Rapid elimination and redistribution
56
Dosining and Clinical Effects of Dilaudid
Commercial preparation 1 mg/cc or 2 mg/cc Dosing IVP: 0.5 – 1 mg Often used in post op PCA pump
57
Carfentanil Basics
Carfentanil, an opioid 10,000 times more powerful than morphine and 100 times more powerful than fentanyl Used in Veterinary medicine in an injection form On October 26, 2002, Russian Special Forces deployed an aerosol form of carfentanil and remifentanil against Chechen terrorists to rescue hostages in the Dubrovka theatre. Caused 125 deaths through respiratory failure. Carfentanil is a considered a weapon by the  Chemical Weapons Convention.
58
What is a significant concern with the use of Carfentanil?
It is 10,000 times more powerful than morphine and considered a weapon
59
Fill in the blank: Codeine is a _______ of morphine.
3-methylmorphine
60
What is the main clinical effect of Hydromorphone?
3-4 times as potent as morphine
61
What is the mechanism of action for Remifentanil?
Selective Mu opioid agonist with a rapid onset and non-cumulative effect
62
What is the primary method of elimination for opioids?
Metabolites are excreted in the urine
63
What is the effect of opioid agonists on the body?
* Analgesia * Euphoria * Sedation * Diminished ability to concentrate
64
What is the significance of the Harrison Narcotics Act of 1914?
It criminalized narcotic possession
65
What are the clinical considerations of Meperidine?
* Cardiovascular effects: ↓BP, ↑HR * Respiratory: ventilation depression * CNS: delirium, seizures
66
What is the dose range for IV Morphine?
1 - 2 mg
67
What is the dose range for IV Fentanyl?
1 mcg/kg or 50 – 100 mcg
68
What is the effect of a methyl group substitution for an alcohol at C #3 of morphine?
Limits 1st pass hepatic metabolism ## Footnote This modification affects the metabolism of morphine, influencing its pharmacological properties.
69
What is the percentage of morphine that is converted to norcodeine?
90% ## Footnote Norcodeine is considered an inactive metabolite of morphine.
70
Generalized Equianalgesic Dosing
Codeine – 100mg Morphine – 10 mg Dilaudid – 1 mg (to 2mg depends on text) Fentanyl – 100 mcg Sufentanyl – 10 mcg
71
Codeine – 3-methylmorphine
Natural-occurring phenanthrene Results from a methyl group substituted for an alcohol at C #3 of morphine This limits 1st pass hepatic metabolism de-Methylation in liver  Morphine 10% 90% is norcodeine – inactive Oral antitussive, IM analgesic
72
Oxymorphone
Add a alcohol to hydromorphone 10X as potent as morphine More N/V Physical dependence
73
Oxycondone
Oxy Contin has a high abuse potential Rapid and powerful opioid effects
74
Hydrocodone
Vicodan High abuse potential
75
Methadone
Synthetic opioid agonist Highly effective by oral route Used for suppression of w/drawl symptoms in dependent (heroin addict) Substitute for morphine but 1/4th the dose
76
Tramadol
5-10X less potent than morphine Mix of two enantiomers, one inhibits NE the other acts on mu receptors Metabolized by hepatic P450 to desmethyltramadol
77
Heroin (diacetylmorphine)
Is a synthetic opioid activated by acetylation to morphine It rapidly enters the brain and is hydrolyzed to active metabolites monoacetylmorphine and morphine Heroin has a rapid onset, lack of N/V effect and high dependency
78
What is oxymorphone and how does it compare to morphine in terms of potency?
10X as potent as morphine ## Footnote Oxymorphone is derived from hydromorphone and has increased side effects, including nausea and vomiting.
79
What is the primary use of oxycodone?
Oral analgesic with high abuse potential ## Footnote Oxy Contin is a formulation of oxycodone known for its rapid and powerful opioid effects.
80
What is methadone and its primary clinical use?
Synthetic opioid agonist used for withdrawal symptom suppression ## Footnote Methadone can be used as a substitute for morphine, typically at a quarter of the dose.
81
Opioid Agonist-Antagonist
Bind to Mu receptors to produce limited (partial agonist) or no effects (competitive antagonist) Similar side effects Advantages = produce analgesia w/ limited depression of ventilation and low dependence due to ceiling effect Commonly given to treat withdrawal symptoms
82
Opioid Receptor Antagonist
Naloxone (Narcan) Pure opioid receptor antagonist at μ receptors Displaces agonist and binds to receptors Onset: < 60 seconds Duration: 30 – 45 minutes
83
Narcan Clinical Considerations and Packaging/Dosing
Associated N/V after rapid IV administration (slow push) Cardiovascular stimulation Neonatal withdrawal Commercial preparation 0.4 mg/cc nalaxone hydrochloride Dosing 1 – 4 mcg/kg IVP 40 mcg q 60s Infusion: 5 mcg/kg/hr
84
COX & NSAIDs – Clinical Uses
Aspirin protypical NSAID Hippocrates wrote about using powder from willow bark for pain and fever in 5th century BC 20th Century Bayer scientist acetylsalicylic acid and marketed Aspirin for pain/fever Anti-inflammation Analgesic Anti-pyretic Treatment of gout Prophylaxis of heart disease (MI and stroke) Prophylaxis of colorectal cancer Treatment of Alzheimer’s Dz
85
COX and NSAIDs Mechanism of Action
86
Cyclooxygenase (COX)
COX activity is associated with two isoenzymes COX-1 Found in gastric mucosa, renal parenchyma, and platelets Essential in platelet agg., GI mucosal integrity, and renal function COX-2 Inducible Expressed mainly at sites of injury Mediates inflammation, fever, pain
87
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
All-encompassing classification of drugs possessing analgesic, anti-inflammatory, and anti-pyretic (fever) effects Categorization Non-specific COX inhibitors Aspirin & NSAIDs COX-2 selective inhibitors Beneficial effects Pain relief Attenuation of inflammatory processes No dependence or addiction potential Synergistic effects with opioids No ventilatory depression No associated N/V
88
NSAIDs Adverse Side-effects
Adverse side-effects ↓platelet aggregation Gastric ulceration Renal dysfunction ↑asthmatic bronchospasm
89
Non-Specific COX Inhibitors - Aspirin (acetyl salicylic acid (ASA))
Irreversibly acetylates COX Clinical indications Analgesia (low-intensity pain) Anti-pyretic Anti-platelet for prevention of MI Clinical considerations GI intolerance and ulceration Anticoagulant effects Aspirin-induced asthma
90
Non-Specific COX Inhibitors - Proprionic Acid Derviatives
Clinically used agents Ibuprofen (Advil®, Motrin®) Naproxen (Alleve®) Tiaprofenic acid (Surgam®) Diclofenac (Voltaren®) Clinical considerations Extensive plasma albumin binding
91
Non-Specific COX Inhibitors - Ketorolac (Toradol)
Proprionic acid derivative Dosing: 30 mg IV or IM Analgesic equivalent to 10 mg of MSO4 Clinical considerations Inhibition of platelet aggregation Cross-tolerance with aspirin Life-threatening bronchospasm in aspirin-induced asthma Old studies show renal damage but now no indication of renal toxicity
92
Non-Specific COX Inhibitors - Acetaminophen (Tylenol)
Not a true NSAID, but exhibits strong central inhibition of prostaglandin synthesis Analgesic and antipyretic effects, but no anti-inflammatory mechanisms Clinical considerations No anticoagulant effects Chronic use can lead to renal medullary ischemia Hepatotoxicity IV acetaminophen (Ofirmev®) Old drug new use Dosage & Preparation Peds: 10 – 15 mg/kg IV or suppository IV: 1 g q 6 hrs max dose 4 g Comes in 1000 mg in 100 ml Given over 15 min
93
COX-2 Inhibitors
Exhibit analgesic efficacy, w/o effects on platelets and GI tract Commonly used agents Celecoxib (Celebrex®) Rofecoxib (Vioxx®) Valdecoxib (Bextra®) Meloxicam (Mobic®) Indications for clinical use Osteoarthritis Rheumatiod arthritis Acute gout Dysmenorrhea Post-operative pain Prevention of Alzheimer’s disease*
94
COX-2 Inhibitors and CV thrombotic events and MI
Imbalance between the prothrombotic and vasoconstricting activity of thromboxane A2 (TXA2), and the antithrombotic and vasodilatory effects of prostacyclin (PGI2), thereby favoring deleterious thromboxane effects Rofecoxib and valdecoxib (both discontinued) are associated with significant ischemic stroke risk In 2005, a consensus statement issued by the Food and Drug Administration (FDA) Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee concluded that COX-2 selective agents that the preponderance of data demonstrates that the cardiovascular risk associated with celecoxib is similar to that associated with commonly used, older, nonselective NSAIDs COX-2 inhibitors do not affect platelet function and should be considered when there are concerns regarding postoperative hemostasis
95
What is tramadol and how does it act pharmacologically?
5-10X less potent than morphine, inhibits NE and acts on mu receptors ## Footnote Tramadol is metabolized by hepatic P450 to desmethyltramadol.
96
How is heroin activated and what are its effects?
Activated by acetylation to morphine, has rapid onset and high dependency ## Footnote Heroin is hydrolyzed to monoacetylmorphine and morphine, leading to its potent effects.
97
What is the function of opioid agonist-antagonists?
Bind to Mu receptors to produce limited or no effects ## Footnote These agents provide analgesia with limited respiratory depression and low dependence.
98
What is naloxone and its characteristics?
Pure opioid receptor antagonist at μ receptors, displaces agonist ## Footnote Onset is less than 60 seconds with a duration of 30-45 minutes.
99
What are the clinical considerations for administering naloxone?
Associated N/V after rapid IV administration, cardiovascular stimulation ## Footnote Caution is advised due to potential neonatal withdrawal effects.
99
100
What is the mechanism of action for aspirin?
Irreversibly acetylates COX ## Footnote Aspirin is a prototypical NSAID with various clinical uses including analgesic and anti-inflammatory.
101
List the clinical uses of aspirin.
* Anti-inflammation * Analgesic * Anti-pyretic * Treatment of gout * Prophylaxis of heart disease * Prophylaxis of colorectal cancer * Treatment of Alzheimer's disease ## Footnote Aspirin has a long history of use dating back to ancient medicine.
102
What are the two isoenzymes associated with COX activity?
* COX-1 * COX-2 ## Footnote COX-1 is essential for normal physiological functions, while COX-2 is inducible in response to injury.
103
What are the adverse side effects of NSAIDs?
* ↓ platelet aggregation * Gastric ulceration * Renal dysfunction * ↑ asthmatic bronchospasm ## Footnote These side effects highlight the need for careful monitoring when using NSAIDs.
104
List some common non-specific COX inhibitors.
* Ibuprofen * Naproxen * Tiaprofenic acid * Diclofenac ## Footnote These agents are used clinically for pain relief and inflammation.
105
What is acetaminophen and its primary effects?
Exhibits strong central inhibition of prostaglandin synthesis, analgesic and antipyretic effects ## Footnote It does not have anti-inflammatory mechanisms.
106
What are the common indications for COX-2 inhibitors?
* Osteoarthritis * Rheumatoid arthritis * Acute gout * Dysmenorrhea * Post-operative pain * Prevention of Alzheimer’s disease ## Footnote COX-2 inhibitors are designed to provide analgesia without affecting platelet function.
107
Introduction to Suzetrigine
FDA approved in Jan of 2025 for moderate to serve pain First FDA approved pain medication in 20 years Target: Selective inhibition of voltage-gated sodium channel NaV in the PNS. This slide introduces Suzetrigine, a non-opioid investigational analgesic developed by Vertex Pharmaceuticals. Its focus is on treating moderate-to-severe pain by selectively targeting the NaV1.7 sodium channel, which plays a key role in pain signaling.
108
What is the primary action of Suzetrigine?
Blocks NaV1.7 sodium channels crucial in nociceptive signaling NaV1.7 Role: Amplifies pain signals in sensory neurons Selectivity: High selectivity for NaV1.7 over other NaV subtypes (e.g., NaV1.5, NaV1.6) Outcome: Reduces pain perception without central nervous system depression ## Footnote This selectivity helps reduce pain perception without central nervous system depression.
109
Pharmacokinetics of Suzetrigine
Absorption: Oral bioavailability reported in early studies Distribution: Likely peripheral action, minimal CNS penetration Metabolism: Under investigation – presumed hepatic Half-Life: Under study; candidate for once-daily dosing Excretion: Renal and/or biliary elimination anticipated The pharmacokinetics of Suzetrigine are still being fully characterized. However, it's expected to be orally bioavailable and largely peripheral in action. Once-daily dosing may be possible based on its half-life.
110
Clinical Efficacy and Trials of Suzetrigine
Indications Studied: - Acute pain (e.g., abdominoplasty, bunionectomy) - Chronic neuropathic pain (e.g., diabetic peripheral neuropathy) Phase II Results: - Significant reduction in pain scores vs. placebo with 50mg to 100mg BID dosing - Well tolerated, minimal CNS or GI side effects Suzetrigine has shown promise in Phase II trials for both acute and chronic pain conditions. The current Phase III trials aim to establish its safety profile and optimal dosing regimen.
111
What outcomes were observed in Phase II trials for Suzetrigine?
* Significant reduction in pain scores vs. placebo * Well tolerated with minimal CNS or GI side effects ## Footnote Dosages studied were 50mg to 100mg BID.